Bristol Advisors’s Abbott ABT Stock Holding History

Bristol Advisors’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,100	Closed	-$272K	–	85
2017 Q3	$272K	Buy	+5,100	New	+$256K	0.27%	54

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bristol Advisors's ABT Position: Q4 2017 in Review

Bristol Advisors sold out of Abbott (ABT) in Q4 2017, closing a stake of 5,100 shares — an estimated $272K sold.

Bristol Advisors first reported a position in ABT in Q3 2017 and held it in 1 quarter. The position peaked at $272K in Q3 2017. 1,752 funds tracked by Wall St. Rank hold ABT as of Q4 2017.

Bristol Advisors reported no remaining Abbott position as of Q4 2017 after selling out during the quarter.
Bristol Advisors sold 5,100 Abbott shares in Q4 2017, an estimated $272K.
Bristol Advisors first reported a position in Abbott in Q3 2017 and held it in 1 quarter.
Bristol Advisors's Abbott position peaked at $272K in Q3 2017.
1,752 funds tracked by Wall St. Rank held Abbott as of Q4 2017.

Based on Bristol Advisors's 13F filing for Q4 2017, filed 12 Jan 2018.